SCHEMBL19975778

SCHEMBL19975778

C[N@+]12CC[N@+](C)(CC1)CC2

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.50
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3391562 1.00 CHRNA7 (0.50) CHRNA7KDM4E
Water SCHEMBL20473028 0.94 CHRNA7 (0.47) CHRNA7KDM4E
Bromide SCHEMBL17055042 0.82 CHRNA7 (0.39) CHRNA7KDM4E
SCHEMBL25874159 0.78 CHRNA7 (0.37) CHRNA7
SCHEMBL9206869 0.78 CHRNA7 (0.37) CHRNA7
SCHEMBL841576 0.78
Iodide SCHEMBL5146160 0.76 CHRNA7 (0.35) CHRNA7KDM4E
Hydrochloric Acid SCHEMBL1502874 0.76 CHRNA7 (0.35) CHRNA7KDM4E
Bromide SCHEMBL1502904 0.76 CHRNA7 (0.35) CHRNA7KDM4E
Hydrochloric Acid SCHEMBL1502870 0.73 CHRNA7 (0.33) CHRNA7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230386840-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICES AND PATTERN FORMATION METHOD TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2023-11-30 US disclosed
US-20230386840-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICES AND PATTERN FORMATION METHOD TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2023-11-30 US disclosed
US-11725145-B2 Coating-type polarizing film using diacetylene-based lyotropic liquid crystal mixture containing iodines, and manufacturing method therefor INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY (KR) 2023-08-15 US disclosed
US-20230183489-A1 COLORING COMPOSITION, INK JET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND COLORING AGENT COMPOUND FUJIFILM CORPORATION (JP) 2023-06-15 US disclosed
US-11215924-B2 Photoresist, developer, and method of forming photoresist pattern TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2022-01-04 US disclosed
US-20200328075-A1 CLEANING SOLUTION AND METHOD OF CLEANING WAFER TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2020-10-15 US disclosed
US-20200073238-A1 PHOTORESIST, DEVELOPER, AND METHOD OF FORMING PHOTORESIST PATTERN TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2020-03-05 US disclosed
EP-2831264-B1 BACTERIAL IMAGING AGENTS AND METHODS OF USING SAME VISEN MEDICAL INC (US) 2019-07-10 EP disclosed
US-20180155353-A1 Antimicrobial Compounds and Methods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2018-06-07 US disclosed
US-9920062-B2 Antimicrobial monomers and polymers, and their use in dental devices BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2018-03-20 US disclosed
US-20080300252-A1 EMBEDDING ANTIBIOTIC COMPOUNDS IN SOLID POLYMERS PACE UNIVERSITY 2008-12-04 US disclosed
US-20080299070-A1 Antiviral Compounds LONG ISLAND UNIVERSITY 2008-12-04 US disclosed
US-20080299070-A1 Antiviral Compounds LONG ISLAND UNIVERSITY 2008-12-04 US disclosed
WO-2008105822-A2 ANTIMICROBIAL COMPOSITIONS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2008-09-04 WO disclosed
US-20080203354-A1 POLISHING LIQUID FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
US-20080145782-A1 IMAGE RECORDING MATERIAL AND NOVEL COMPOUND FUJIFILM CORPORATION (JP) 2008-06-19 US disclosed
US-20080081286-A1 Optical information recording medium and azo-metal complex dye FUJIFILM CORPORATION (JP) 2008-04-03 US disclosed
US-20080081286-A1 Optical information recording medium and azo-metal complex dye FUJIFILM CORPORATION (JP) 2008-04-03 US disclosed
US-20070072812-A1 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones MICROBIA, INC. (US) 2007-03-29 US disclosed
US-20070072812-A1 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones MICROBIA, INC. (US) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300252-A1 EMBEDDING ANTIBIOTIC COMPOUNDS IN SOLID POLYMERS NUP205, SEPTIN7, SEPTIN6 CHRNA7 4844/4885KDM4E 288/4885
US-20080299070-A1 Antiviral Compounds EIF2AK2, MAVS, SARS1 CHRNA7 4864/4885KDM4E 429/4885
US-20070072812-A1 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones PCSK9, SLC10A1, QDPR CHRNA7 4773/4885KDM4E 364/4885
US-20180155353-A1 Antimicrobial Compounds and Methods GSDMD, AAAS, ACMSD CHRNA7 4883/4885KDM4E 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.